Prognostic and predictive markers in recurrent high-grade glioma (HGG): Results from the BR12 randomized trial.

被引：2

作者：

Brada, M.

Collins, V. P.

Ichimura, K.

Thompson, L. C.

Gabe, R.

Stenning, S. P.

机构：

[1] Inst Canc Res, Sutton, Surrey, England

[2] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[3] Addenbrookes Hosp, Dept Pathol & Mol Histopathol, Cambridge, England

[4] Univ Cambridge, Dept Pathol, Addenbrookes Hosp, Cambridge CB2 1QP, England

[5] MRC, Clin Trials Unit, London, England

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.2035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

2035

引用

页数：1